Clinical Trial Update: Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial of talimogene laherparepvec in children with advanced non-CNS tumors has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-cns Tumors

Drugs mentioned

• Talimogene laherparepvec (talimogene laherparepvec)

Snippet

Sponsor: Amgen | Conditions: Advanced Non CNS Tumors | Phase 1 | Status: COMPLETED | Results posted: 2024-02-05